| SPI1 |
Homo sapiens |
|
SPI1 is differentially expressed in 76 experiments [81 up/76 dn]: 17 organism parts: kidney [1 up/1 dn], whole blood [1 up/0 dn], ...; 18 disease states: normal [2 up/7 dn], glioblastoma [3 up/0 dn], ...; 27 cell types, 27 cell lines, 13 compound treatments and 17 other conditions. |
| SPI1 |
|
spi1 (Danio rerio)
Sfpi1 (Mus musculus)
(Compare orthologs)
|
|
|
| Ets, Winged helix-turn-helix transcription repressor DNA-binding |
|
|
| RNA binding, negative regulation of transcription from RNA polymerase II promoter, nucleus, protein binding, sequence-specific DNA binding |
|
|
|
P17947
|
|
|
|
ENSG00000066336
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Glioblastoma
|
Disease state |
|
|
None
|
Compound treatment |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
MCF-7
|
Cell line |
|
|
Kidney
|
Organism part |
|
|
HL-60
|
Cell line |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
MCF7
|
Cell line |
|
|
PC3
|
Cell line |
|
|
SKMEL5
|
Cell line |
|
|
T cell
|
Cell type |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
Grade IV
|
Tumor grading |
|
|
Whole blood
|
Organism part |
|
|
Primary gastric tumor
|
Organism part |
|
|
BJAB
|
Cell line |
|
|
HPL1
|
Cell line |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
Spermatid
|
Cell type |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Caudate nucleus
|
Organism part |
|
|
HeLa
|
Cell line |
|
|
Chondrocyte
|
Cell type |
|
|
KSHV-negative EBV-positive
|
Clinical info |
|
|
Pancreas
|
Organism part |
|
|
Acute lymphocytic leukemia
|
Disease state |
|
|
Spleen
|
Organism part |
|
|
Heart
|
Organism part |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
SsMCF7
|
Cell line |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
IgV status unknown
|
Genotype |
|
|
Unknown_sex
|
Sex |
|
|
Lung
|
Organism part |
|
|
N/a
|
Test result |
|
|
Bone marrow
|
Organism part |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Testis
|
Organism part |
|
|
BCKN-1
|
Cell line |
|
|
Ductal carcinoma in situ
|
Disease state |
|
|
Invasive ductal carcinoma
|
Disease state |
|
|
IgV mutated
|
Genotype |
|
|
Trichostatin A
|
Compound treatment |
|
|
Epilepsy
|
Disease state |
|
|
Primary
|
Disease staging |
|
|
CD16+ dendritic cell
|
Cell type |
|
|
293
|
Cell line |
|
|
Native skin
|
Cell type |
|
|
Breast carcinoma
|
Disease state |
|
|
Primary bone marrow CD34+ stem...
|
Cell type |
|
|
HaCaT
|
Cell line |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Drug-naive
|
Clinical treatment |
|
|
Seminiferous tubule
|
Organism part |
|
|
Skeletal muscle
|
Organism part |
|
|
CD8+ T cell
|
Cell type |
|
|
HMEC184
|
Cell line |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Baseline uninfected
|
Disease state |
|
|
Cartilage
|
Organism part |
|
|
Not applicable
|
Histology |
|
|
Fibroblast
|
Cell type |
|
|
Endothelial cell
|
Cell type |
|
|
KSHV-positive EBV-negative
|
Clinical info |
|
|
Peripheral blood
|
Organism part |
|
|
Total_RNA
|
Material type |
|
|
Polysome-associated RNA
|
Material type |
|
|
Hematopoietic stem cell
|
Cell type |
|
|
Adipose tissue-derived stem ce...
|
Cell type |
|
|
SM1
|
Cell line |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Diagnosed with skin cancer bef...
|
Clinical history |
|
|
Female
|
Sex |
|
|
Skin
|
Organism part |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Brain
|
Organism part |
|
|
Ulcerative colitis
|
Disease state |
|
|
Viral load medium
|
Clinical history |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
BC-2
|
Cell line |
|
|
MCF10A
|
Cell line |
|
|
CD34+
|
Cell type |
|
|
Homo sapiens
|
Organism |
|
|
Spermatocyte
|
Cell type |
|
|
Macaca mulatta
|
Organism |
|
|
Osteoblast
|
Cell type |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
1,10-phenanthroline
|
Compound treatment |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
PEL-5
|
Cell line |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
Sham surgery
|
Clinical treatment |
|
|
CD19+ B cells (neg. sel.)
|
Cell type |
|
|
Granulocyte-colony stimulating...
|
Compound treatment |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Male
|
Sex |
|
|
HMEC S1
|
Cell line |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
IBL4
|
Cell line |
|
|
Pan troglodytes
|
Organism |
|
|
Limited radiation toxicity
|
Clinical history |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
T47-D
|
Cell line |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
Adipose-derived stem cell
|
Cell type |
|
|
MS589
|
Cell line |
|
|
Rapamycin
|
Compound treatment |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Monocyte
|
Cell type |
|
|
Epithelial cell
|
Cell type |
|
|
Stromal cell
|
Cell type |
|
|
BT-474
|
Cell line |
|
|
ITM-E6E7-ST
|
Cell line |
|
|
R-(-)-apomorphine HCl
|
Compound treatment |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Stimulated polymorphonuclear l...
|
Cell type |
|
|
Unstimulated polymorphonuclear...
|
Cell type |
|
|
Hydrogen peroxide
|
Compound treatment |
|
|
Non-ischemic cardiomyopathy
|
Disease state |
|
|
|
|
|
Processing time: 0.1 secs.